IRIDEX Corporation
IRIX
Rank in Stocks
#28092
IRIDEX Corporation is a medical technology firm specializing in ophthalmology.... IRIDEX Corporation is a medical technology firm specializing in ophthalmology. They develop and supply advanced therapeutic laser systems, various delivery instruments, and essential consumable tools designed to address vision-threatening ocular conditions. Their product portfolio includes several laser consoles, each tailored for specific eye conditions. The Cyclo G6 system is specifically engineered for glaucoma treatment. For ailments like diabetic macular edema and other retinal pathologies, IRIDEX provides the IQ 532 and IQ 577 laser photocoagulation systems. Furthermore, the OcuLight series, encompassing models such as TX, SL, SLx, GL, and GLx, offers solutions for managing severe retinal issues like proliferative diabetic retinopathy, macular holes, and retinal tears or detachments. Beyond laser consoles, the company also manufactures specialized delivery instruments. These include the TxCell scanning laser delivery system, which empowers clinicians with multi-spot pattern scanning capabilities. A unique slit lamp adapter enables practitioners to integrate standard slit lamps into their diagnostic and therapeutic workflows. Additionally, a laser indirect ophthalmoscope is available for interventions targeting peripheral retinal disorders. IRIDEX's offerings extend to various probes. The MicroPulse P3 Probe, when coupled with the Cyclo G6 laser system, facilitates MicroPulse transscleral laser therapy. For managing uncontrolled glaucoma, the G-Probe is employed, while both the G-Probe and G-Probe Illuminate are utilized in procedures addressing refractory glaucoma. The EndoProbe product line supports a range of vitrectomy procedures. Their diverse client base spans ophthalmology professionals, academic and research hospitals, government healthcare facilities, specialized surgical centers, general hospitals, veterinary clinics, and private medical practices. Product distribution is handled via an internal and independent sales network across the United States, supplemented by independent distributors for its international markets. Originally incorporated in 1989 as IRIS Medical Instruments, Inc., the company adopted the name IRIDEX Corporation in November 1995. Its corporate headquarters are situated in Mountain View, California.
Share Price
$0.7062
Last synced: 2026-11-09
Market Cap
$12.40M
Change (1 day)
7.42%
Change (1 year)
-40.66%
Country
Stock data: Financial Modeling PrepΒ·Updated Β·Not investment adviceΒ·How we calculate this
Trade IRIDEX Corporation (IRIX)
Category
Healthcare
EPS for IRIDEX Corporation (IRIX)
EPS as of July 2026 TTM: $-0.20
According to IRIDEX Corporation's latest financial reports, its current EPS (TTM) is $-0.20. At the end of 2024 the company had an EPS of $-0.54, an increase over its 2023 EPS of $-0.59.
EPS history for IRIDEX Corporation from 2000 to 2026
EPS at the end of each year
| Year | EPS | Change |
|---|---|---|
| 2026 (TTM) | $-0.20 | -62.96% |
| 2024 | $-0.54 | -8.47% |
| 2023 | $-0.59 | 25.53% |
| 2022 | $-0.47 | 38.24% |
| 2021 | $-0.34 | -26.09% |
| 2020 | $-0.46 | -28.13% |
| 2019 | $-0.64 | -39.05% |
| 2018 | $-1.05 | -5.41% |
| 2017 | $-1.11 | -3.48% |
| 2016 | $-1.15 | -2,400.00% |
| 2015 | $0.05 | -95.05% |
| 2014 | $1.01 | 320.83% |
| 2013 | $0.24 | 50.00% |
| 2012 | $0.16 | -44.83% |
| 2011 | $0.29 | -14.71% |
| 2010 | $0.34 | 17.24% |
| 2009 | $0.29 | -134.52% |
| 2008 | $-0.84 | -68.77% |
| 2007 | $-2.69 | 258.67% |
| 2006 | $-0.75 | -426.09% |
| 2005 | $0.23 | -512.19% |
| 2004 | $-0.06 | -211.60% |
| 2003 | $0.05 | 150.00% |
| 2002 | $0.02 | -110.53% |
| 2001 | $-0.19 | -152.78% |
| 2000 | $0.36 | 0.00% |
EPS for similar companies or competitors
| Company | EPS | EPS Difference | Country |
|---|---|---|---|
| $2.70 | -1,450.00% |
US
|
|
| $4.09 | -2,145.00% |
IE
|
|
| $9.45 | -4,825.00% |
US
|
|
| $2.37 | -1,285.00% |
US
|
|
| $1.77 | -985.00% |
US
|
Questions about IRIDEX Corporation's earnings per share (EPS)
What is IRIDEX Corporation's earnings per share (EPS)?
IRIDEX Corporation's earnings per share (EPS) over the last twelve months is $-0.20, as of Jul 2026.
What was IRIDEX Corporation's earnings per share (EPS) in 2024?
In 2024, IRIDEX Corporation's earnings per share (EPS) was $-0.54, compared with $-0.59 in 2023.
How has IRIDEX Corporation's earnings per share (EPS) changed since 2019?
From 2019 to 2024, IRIDEX Corporation's earnings per share (EPS) was highest in 2021 ($-0.34) and lowest in 2019 ($-0.64).
How does IRIDEX Corporation's earnings per share (EPS) compare with similar companies?
IRIDEX Corporation's earnings per share (EPS) ($-0.20) is lower than that of all 5 similar companies listed above. The highest among them is Stryker Corporation, with $9.45.